Back
Day Range
$43.46
$45.92
52-Week Range
$22.71
$49.82
Volume
1,267,776
50D / 200D Avg
$45.04
/
$38.36
Prev Close
$44.64
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -13.3 | 0.4 |
| P/B | 20.4 | 2.9 |
| ROE % | -123.1 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.4 | 0.2 |
Key Takeaways
Debt/Equity of 0.44 — conservative balance sheet
Negative free cash flow of -300.64M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-123.08%
ROIC-81.40%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.44
Current Ratio6.95
Interest Coverage-55.80
Valuation
P/E Ratio
-13.27
P/B Ratio20.43
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -377.94M |
| ROE | -123.08% | ROA | -93.49% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -300.64M |
| ROIC | -81.40% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.44 | Current Ratio | 6.95 |
| Interest Coverage | -55.80 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -13.27 | P/B Ratio | 20.43 |
| P/S Ratio | N/A | PEG Ratio | -0.40 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 5.02B | Enterprise Value | 4.80B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 33.19M | 18.82M |
| Net Income | -377.94M | -246.29M | -165.79M | -134.50M | -131.80M |
| EPS (Diluted) | -3.29 | -2.47 | -1.99 | -2.21 | -3.59 |
| Gross Profit | -1.66M | -1.94M | -2.84M | -89.85M | -89.65M |
| Operating Income | -384.65M | -252.05M | -171.30M | -134.37M | -129.92M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 404.27M | 474.92M | 311.04M | 358.17M | 304.45M |
| Total Liabilities | 158.78M | 106.29M | 85.82M | 97.93M | 132.37M |
| Shareholders' Equity | 245.49M | 368.63M | 225.22M | 260.24M | 172.07M |
| Total Debt | 108.92M | 65.13M | 61.82M | 69.40M | 84.47M |
| Cash & Equivalents | 323.53M | 177.88M | 101.86M | 103.28M | 212.84M |
| Current Assets | 385.15M | 451.17M | 288.19M | 328.02M | 265.32M |
| Current Liabilities | 55.42M | 46.94M | 32.74M | 36.39M | 64.30M |